Description
Chymotrypsin Tablets
Chymotrypsin (Trypsin-Chymotrypsin) Tablets
Healthy Life Pharma Private Limited, alongside our specialized global marketing and export division Healthy Inc, is a premier manufacturer, supplier, and exporter of advanced orthopedic, surgical recovery, and anti-inflammatory therapeutics. We manufacture ultra-high-purity, kinetically stable Chymotrypsin (Trypsin-Chymotrypsin FDC) Tablets in our WHO–GMP certified, climate-controlled solid dosage manufacturing facilities. This “Systemic Proteolytic Enzyme Therapy” acts as a massive-volume strategic export to orthopedic centers, surgical hospitals, government health tenders, and international B2B distributors, serving as the globally preferred biological intervention for the rapid reduction of post-traumatic and post-operative swelling.
Product Overview
This formulation operates as a “Biological Debridement and Micro-Circulatory Restorer.” It ensures patient safety by accelerating the body’s natural tissue-repair mechanisms without the gastric or systemic side effects associated with high-dose steroid or NSAID overuse.
Mechanism 1 (Fibrinolytic Cascade Activation): Chymotrypsin physically hydrolyzes peptide bonds in proteins, specifically targeting Fibrin polymers deposited at the site of acute inflammation. This chemically breaks down the physical “fibrin barrier” that walls off the inflamed tissue.
Mechanism 2 (Edema and Hematoma Resolution): By clearing the fibrin blocks, it physically thins out inflammatory fluids and blood clots (hematomas). This chemically facilitates Rapid Lymphatic Drainage, physically reducing tissue swelling, tension, and localized pain.
Mechanism 3 (Micro-Circulatory Restoration): Restoring normal fluid flow physically opens up blocked capillaries. This chemically boosts the localized penetration of co-administered antibiotics or analgesics, accelerating the overall tissue healing profile.
Product Composition & Enzyme Potency
We supply this product as a synergistic Trypsin-Chymotrypsin Fixed-Dose Combination (FDC), calibrated in Armour Units (AU) for maximum biological activity.
| Active Ingredient Mixture | Enzyme Ratio | Standard Potency Options | Primary Clinical Function |
| Trypsin & Chymotrypsin IP/BP/USP | 6:1 | 50,000 Armour Units (AU) | Maintenance Recovery: For standard soft-tissue trauma and mild post-operative edema. |
| Trypsin & Chymotrypsin IP/BP/USP | 6:1 | 100,000 Armour Units (AU) | High-Intensity Therapy: For major orthopedic adjustments, dental extractions, and large hematomas. |
Technical & Logistics Specifications
HS Code: 3004.90.99 (Medicaments containing enzymes / Others)
CAS Numbers: 9004-07-3 (Chymotrypsin) / 9002-07-7 (Trypsin)
Dosage Form: Oral Enteric-Coated Tablet (to prevent gastric enzyme inactivation)
Packaging: 10 Tablets per Blister in high-barrier Alu-Alu (Cold-Form Foil). Our premium packaging configurations protect the live enzymes from thermal and moisture degradation, guaranteeing a 24-month shelf life in Zone IVb tropical export climates.
Manufacturing Authority & Compliance
Enteric-Coated Acid-Protection Matrix: Proteolytic enzymes are physically destroyed by gastric acid. Our manufacturing process utilizes an Advanced Enteric Coating System, physically ensuring the tablet passes through the stomach intact and chemically releases the active enzymes only within the alkaline environment of the small intestine.
Low-Temperature Environment Controls: Live enzymes are physically sensitive to heat and moisture. We utilize specialized Cold-Granulation Protocols and Dehumidified Production Suites (RH <35%), physically preventing the enzymes from losing their biological potency during high-volume compression.
Strict Biological Assay Standardization: Every single production batch is chemically verified via Enzymatic Activity Assays, physically proving that the minimum required Armour Units remain active up to the final date of expiration.
Primary Indications
Surgical Recovery: Prevention and treatment of post-operative swelling in Orthopedic, Dental, Gynecological, and Plastic Surgeries.
Traumatology: Rapid resolution of swelling due to Fractures, Sprains, Strains, and Sports Injuries.
Dermatology & General Surgery: Management of severe Hematomas, Contusions, and Deep Tissue Abscesses.
Usage Instructions
Administration: Swallow the tablet physically whole with a glass of water. Do not crush, chew, or break the tablet, as destroying the enteric coating chemically ruins the enzyme potency.
The Empty Stomach Directive: It is physically critical to take this medication on an empty stomach (1 hour before or 2 hours after meals). If taken with food, the enzymes will chemically waste their potency digesting dietary proteins instead of systemic inflammation.
Dosage: Typically 1 to 2 tablets three times daily, depending on the severity of the inflammatory trauma.
Safety Warning: For Oral Use Only. Coagulation Note: Because proteolytic enzymes have mild fibrinolytic properties, use with physical caution in patients with blood clotting disorders or those on active anticoagulant therapy. Allergy Note: Derived from biological sources; monitor chemically for rare hypersensitivity reactions. Contraindication: Do not use in patients with severe hepatic or renal impairment, active peptic ulcers, or known hypersensitivity to Trypsin or Chymotrypsin.
Global Export & Contract Manufacturing (CDMO Services)
Healthy Life Pharma Private Limited provides fully validated Third-Party Contract Manufacturing (CDMO) for enteric-coated Chymotrypsin tablets. Whether you are supplying a National Surgical Program in Africa, a trauma hospital infrastructure in the CIS, or a fast-moving B2B Pharma Marketplace in SE Asia or LATAM, we handle all technical documentation (COA, Stability Data, Dossiers) for rapid international clearing.
Commercial & Bulk Inquiries:
WhatsApp/Call: +91 7710003340
Email: info@healthyinc.co.in
